Skip to content

A Clinical Study on Symptom Improvement in Depressive Patients Using Transcranial Temporal Interference Stimulation Technology

A Clinical Study on Symptom Improvement in Depressive Patients Using Transcranial Temporal Interference Stimulation Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107445
Enrollment
Unknown
Registered
2025-08-12
Start date
2025-08-16
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression, anxiety, lack of pleasure, etc

Interventions

TI active stimulation group (2mA):TI active stimulation (2mA)
TI active stimulation group (15mA):TI active stimulation (15mA)
TI pseudo stimulus group:TI pseudo stimulus

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Meeting the diagnostic criteria for depression in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); 3. Total score of Hamilton Depression Rating Scale-24 (HAMD-24) >= 20; 4. Right-handed; 5. Normal results in physical examination, medical history, vital signs, routine blood/urine/stool tests, liver and kidney function, electrolytes, electrocardiogram (ECG), electroencephalogram (EEG), and other indicators; 6. Willing to actively cooperate with treatment after fully understanding the safety of transcranial temporal interference stimulation (tTIS), and signing the informed consent form along with their family members.

Exclusion criteria

Exclusion criteria: 1. Aged 65 years; 2. Having a history of severe physical diseases, or depression caused by other psychoactive substances and non-dependent substances; 3. Having metal or electronic devices implanted in the body, such as intracranial metal foreign bodies, cochlear implants, cardiac pacemakers, stents, or other metal foreign bodies; 4. At risk of epileptic seizures, with a history of craniocerebral diseases, head trauma, alcoholism, abnormal electroencephalogram (EEG), MRI evidence of abnormal brain structure, or a family history of epilepsy; 5. Having psychotic symptoms that require combined use of antipsychotic drugs; 6. Having received electroconvulsive therapy (ECT) or other physical therapies within 2 months before enrollment;

Design outcomes

Primary

MeasureTime frame
Symptoms such as anxiety, suicide, sleep issues, and anhedonia;Depressive symptoms;

Secondary

MeasureTime frame
Plasticity indicators such as brain region activation and functional connectivity;Working memory, impulse inhibition ability, etc;

Countries

China

Contacts

Public ContactDongsheng Zhou

Affiliated Kangning Hospital of Ningbo University

wyzhouds@sina.com+86 574 26302565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026